Unveiling the dark side of Moringa: High doses of Moringa oleifera Lam. Leaf extract increase the risk of adenocarcinoma in obesity-induced prostate hyperplasia through hyperhomocysteinemia/miR-155/STAT3 cascade

Bibliographic Information
Authors: Shaker S.E.; Aziz W.M.; Hammam O.A.; Ibrahim N.E.; Shawky H.
Journal: Journal of Ethnopharmacology
Publisher: Elsevier Ireland Ltd
Publication Date: September 2025
Volume / Issue: Volume 353
Article No.: 120373
ISSN: 3788741
DOI: 10.1016/j.jep.2025.120373
Scopus: View on Scopus
PubMed: 40774579
Document Type: Article
Authors and Affiliations
Shaker S.E., Therapeutic Chemistry Department, Pharmaceutical Industries and Drug Research Institute, National Research Centre, Cairo, Dokki, 12622, Egypt; Aziz W.M., Therapeutic Chemistry Department, Pharmaceutical Industries and Drug Research Institute, National Research Centre, Cairo, Dokki, 12622, Egypt; Hammam O.A., Pathology Department, Theodor Bilharz Research Institute, Giza, Egypt; Ibrahim N.E., Microbial Biotechnology Department, Biotechnology Research Institute, National Research Centre, Cairo, Dokki, 12622, Egypt; Shawky H., Therapeutic Chemistry Department, Pharmaceutical Industries and Drug Research Institute, National Research Centre, Cairo, Dokki, 12622, Egypt
Abstract
Ethnopharmacological relevance: Moringa oleifera Lam., known as the “miracle tree”, has been applauded as a complementary medicine, owing to its broad-spectrum health benefits. Aim: This study provides novel insights into the unrecognized risk associated with the use of high-dose M. oleifera Lam. leaf extract (MLE) in an obesity-induced prostate hyperplasia (BPH) rat model. Methods: Dry M. oleifera leaves were water-extracted, and the phytocomposition was determined using HPLC and GC-MS. Obesity-related BPH symptoms were induced in male Sprague Dawley rats receiving a high-fat diet (HFD) for 12 weeks, plus testosterone propionate injected subcutaneously (10 mg/kg/day in corn oil) for 4 weeks. BPH animals received different MLE doses, a reference drug (Prostride), and a combination of MLE + Prostride for 30 days. The therapeutic efficacy of different treatments was assessed in terms of their modulatory effect on obesity-related markers, including body weight, lipid profile, plasma homocysteine (Hcy), and BPH-related markers, including prostate index, androgenic hormones, and prostatic transcriptome of inflammatory/oncogenic/apoptotic mediators. Results: the MLE treatment presented a dose-dependent effect in BPH animals, where the low and medium doses alleviated the BPH symptoms, as indicated by the restoration of redox homeostasis and nearly normalizing the inflammatory, oncogenic, and apoptotic transcriptome in treated prostates, reflected by the reversal of histopathological alterations. Conversely, the high-dose MLE aggravated BPH symptoms and further promoted a protumorigenic milieu through elevating plasma Hcy, which simultaneously upregulated a miR-155/STAT3-mediated oncogenic cascade. Conclusion: These findings emphasize the need for cautious dose optimization in future translational applications of MLE and reinforce the importance of context-specific phytotherapy. © 2025 Elsevier B.V.
Keywords
Chlorogenic acid; Hyperhomocysteinemia; microRNAs; Moringa oleifera; Prostate hyperplasia; Adenocarcinoma; Animals; Diet, High-Fat; Male; Obesity; Plant Extracts; Plant Leaves; Prostatic Hyperplasia; Prostatic Neoplasms; Rats; Rats, Sprague-Dawley; STAT3 Transcription Factor; 2 azido 2,4,4,6,6 pentamethylheptane; androgen; ascorbic acid; caffeic acid; catechin; cinnamic acid; coumaric acid; daidzein; dimethyl(4 phenylphenoxy)octadecyloxy silane; ellagic acid; ferulic acid; finasteride; gallic acid; gallic acid methyl ester; hesperetin; homocysteine; kaempferol; linolenic acid; malic acid; microRNA 155; Moringa oleifera extract; naringenin; palmitic acid; para coumaric acid; pentakis(trimethylsilyl)ether tagatofuranose; prostride; quercetin; rosmarinic acid; rutoside; STAT3 protein; syringic acid; testosterone propionate; transcriptome; trolox C; unclassified drug; vanillin; water; microRNA; plant extract; Stat3 protein, rat; amino acid blood level; animal experiment; animal model; animal tissue; antioxidant activity; apoptosis; Article; body weight; cancer risk; carcinogenesis; chemical composition; controlled study; dose response; drug dose comparison; drug efficacy; drug isolation; drug megadose; high performance liquid chromatography; histopathology; lipid diet; lipid fingerprinting; low drug dose; mass fragmentography; nonhuman; plant leaf; prostate hypertrophy; rat; upregulation; animal; chemistry; complication; drug therapy; etiology; genetics; metabolism; pathology; prostate tumor; Sprague Dawley rat
Citation Information
Scopus Citations: 1
For comprehensive information about the Theodor Bilharz Research Institute (TBRI), its institutional activities, scientific and research achievements, clinical and hospital services, and the diverse expertise offered through its 22 specialized research and clinical departments, as well as opportunities for professional training, specialized workshops, and scientific conferences, readers are invited to visit the Institute’s official website.
The website provides regularly updated information on the Institute’s latest news, research activities, scientific initiatives, clinical services, institutional programs, and academic and professional opportunities.
English Website: https://www.tbri.sci.eg/en/
Arabic Website: https://www.tbri.sci.eg/ar/
Prepared and Uploaded by:
Abdalla F. Abdalla
Electronic Portal Unit
